Pitche P, Mouzou T, Padonou C, Tchangai-Walla K
Service de Dermatologie, CHU-Tokoin, Lomé, Togo.
Med Trop (Mars). 2005 Sep;65(4):359-62.
Dermatological reactions are frequent drug-related complications in patients with HIV infection. The most serious disorders are Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), a.k.a. Lyell's syndrome, that are potentially fatal. The purpose of this report is to describe 8 cases of SJS/TEN observed in Lomé teaching hospital (Togo) after intake of a combination of rifampicin-isoniazid by HIV-infected patients. There were 5 men and 3 women with a mean age of 28 years. All patients presented AIDS. The disorder was SJS in 3 cases and TEN in 5. In 6 cases, manifestations occurred during initiation of treatment (mean delay for onset, 16 days). In the remaining two cases, manifestations occurred 6 days and 8 days respectively after beginning treatment for recurrent tuberculosis. Mean skin detachment was 8% in patients with SJS and 55.7% in patients with TEN. Five patients including 4 with TEN and 1 with SJS died. This study documents incrimination of combined rifampin-isoniazid treatment in the occurrence of SJS/TEN in patients with HIV infection and confirms the severity and poor prognosis of these disorders. The presence of opportunistic infections such as pulmonary tuberculosis may be an unfavourable prognostic factor in immunocompromised patients with these severe dermatological disorders.
皮肤反应是HIV感染患者常见的药物相关并发症。最严重的病症是史蒂文斯-约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN),又称莱尔综合征,有潜在致命风险。本报告旨在描述在洛美教学医院(多哥)观察到的8例HIV感染患者在服用利福平-异烟肼组合药物后发生的SJS/TEN病例。其中有5名男性和3名女性,平均年龄为28岁。所有患者均患有艾滋病。3例为SJS,5例为TEN。6例在治疗开始时出现症状(平均发病延迟时间为16天)。其余2例分别在复发性结核病治疗开始后6天和8天出现症状。SJS患者的平均皮肤剥脱率为8%,TEN患者为55.7%。5名患者死亡,其中4例为TEN,1例为SJS。本研究证明了利福平-异烟肼联合治疗与HIV感染患者发生SJS/TEN有关,并证实了这些病症的严重性和预后不良。机会性感染如肺结核的存在可能是这些严重皮肤病免疫功能低下患者的不良预后因素。